«How will country-based mitigation measures influence the course of the COVID-19 epidemic?». The Lancet395 (10228): 931–934. March 2020. doi:10.1016/S0140-6736(20)30567-5. PMID32164834. «A key issue for epidemiologists is helping policymakers decide the main objectives of mitigation—eg, minimizing morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on the scale and antiviral drug therapies.».
B Gross, Z Zheng, S Liu, X Chen, A Sela, J Li, D Li, S Havlin (2020). «Spatio-temporal propagation of COVID-19 epidemics». Europhysics Letters131 (5): 58003–58008. doi:10.1209/0295-5075/131/58003. Bibcode: 2020EL....13158003G.
De Cock KM (2001). «(Book Review) The Eradication of Smallpox: Edward Jenner and The First and Only Eradication of a Human Infectious Disease». Nature Medicine7 (1): 15–16. doi:10.1038/83283.
Wharton, Melinda E. (2004). «Measles Elimination in the United States». The Journal of Infectious Diseases189 (Supplement_1): S1–S3. doi:10.1086/377693. PMID15106120.
«The global burden of measles in the year 2000—a model that uses country-specific indicators». J. Infect. Dis.187 (Suppl 1): S8–14. May 2003. doi:10.1086/368114. PMID12721886.
Rook, Graham A. W.; Dheda, Keertan; Zumla, Alimuddin (2005). «Immune responses to tuberculosis in developing countries: Implications for new vaccines». Nature Reviews Immunology5 (8): 661–667. doi:10.1038/nri1666. PMID16056257.
B Gross, Z Zheng, S Liu, X Chen, A Sela, J Li, D Li, S Havlin (2020). «Spatio-temporal propagation of COVID-19 epidemics». Europhysics Letters131 (5): 58003–58008. doi:10.1209/0295-5075/131/58003. Bibcode: 2020EL....13158003G.
«How will country-based mitigation measures influence the course of the COVID-19 epidemic?». The Lancet395 (10228): 931–934. March 2020. doi:10.1016/S0140-6736(20)30567-5. PMID32164834. «A key issue for epidemiologists is helping policymakers decide the main objectives of mitigation—eg, minimizing morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on the scale and antiviral drug therapies.».
Wharton, Melinda E. (2004). «Measles Elimination in the United States». The Journal of Infectious Diseases189 (Supplement_1): S1–S3. doi:10.1086/377693. PMID15106120.
«The global burden of measles in the year 2000—a model that uses country-specific indicators». J. Infect. Dis.187 (Suppl 1): S8–14. May 2003. doi:10.1086/368114. PMID12721886.
Rook, Graham A. W.; Dheda, Keertan; Zumla, Alimuddin (2005). «Immune responses to tuberculosis in developing countries: Implications for new vaccines». Nature Reviews Immunology5 (8): 661–667. doi:10.1038/nri1666. PMID16056257.
«How will country-based mitigation measures influence the course of the COVID-19 epidemic?». The Lancet395 (10228): 931–934. March 2020. doi:10.1016/S0140-6736(20)30567-5. PMID32164834. «A key issue for epidemiologists is helping policymakers decide the main objectives of mitigation—eg, minimizing morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on the scale and antiviral drug therapies.».
